Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amylyx Pharmaceuticals, Inc. - Common Stock
(NQ:
AMLX
)
2.135
-0.025 (-1.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amylyx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Analyst Ratings For Amylyx Pharma
July 12, 2024
Via
Benzinga
NVIDIA To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Friday
July 12, 2024
Via
Benzinga
Why Is Small Cap Amylyx Pharmaceuticals Stock Trading Higher On Wednesday?
July 10, 2024
Amylyx Pharmaceuticals acquired avexitide from Eiger BioPharmaceuticals Inc. for $35.1 million. Avexitide, a GLP-1 receptor antagonist, ready for Phase 3 trial for post-bariatric hypoglycemia and...
Via
Benzinga
6 Analysts Assess Amylyx Pharma: What You Need To Know
June 24, 2024
Via
Benzinga
Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
May 10, 2024
Via
Benzinga
AMLX Stock Earnings: Amylyx Pharma Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
AMLX stock results show that Amylyx Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Unveiling 6 Analyst Insights On Amylyx Pharma
April 08, 2024
Via
Benzinga
Amylyx Stock Crashes 80% After Approved ALS Drug Fails Its Pivotal Test
March 08, 2024
The company could now pull Relyvrio off the market.
Via
Investor's Business Daily
Forecasting The Future: 4 Analyst Projections For Amylyx Pharma
March 08, 2024
Via
Benzinga
Amylyx Pharmaceuticals' Investigational Drug Shows Improved Pancreatic Function In Patients With Inherited Disorder
April 10, 2024
Amylyx's AMX0035 data in treating Wolfram syndrome, with interim data indicating positive effects on diabetes progression, visual decline, and overall disease burden. Safety profile consistent.
Via
Benzinga
CNS Disorder-Focused Seelos Therapeutics Plunges To 52-Week Low - Here's Why
March 19, 2024
Seelos Therapeutics updates Phase 2/3 HEALEY ALS trial with SLS-005, showing potential efficacy in subgroup analysis. Explore the latest data on ALS treatment with SLS-005."
Via
Benzinga
3 Pharma Stocks to Sell in March Before They Crash & Burn
March 14, 2024
Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.
Via
InvestorPlace
Dow Gains Over 100 Points; AerSale Shares Plunge After Q4 Results
March 08, 2024
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dipping around 0.5% on Friday. The Dow traded up 0.27% to 38,894.21 while the NASDAQ fell 0.51% to 16,190.52. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks Fall As Chipmakers Retreat From Highs, Bitcoin Pulls Back After $70,000, Gold Rises To $2,200: What's Driving Markets Friday?
March 08, 2024
The stock market is navigating a mixed closing session this week, with the S&P 500 and Nasdaq 100 struggling to stave off a weekly downturn.
Via
Benzinga
Earnings Preview: Amylyx Pharma
February 21, 2024
Via
Benzinga
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 08, 2024
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.
Via
Benzinga
Crude Oil Falls Over 1%; Willdan Group Shares Spike Higher
March 08, 2024
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 80 points on Friday. The Dow traded up 0.21% to 38,874.05 while the NASDAQ fell 0.42% to 16,204.26. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
9 Health Care Stocks Whale Activity In Today's Session
March 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 08, 2024
Via
Benzinga
Why Is Neurodegenerative Diseases-Focused Amylyx Pharmaceuticals Stock Plunging On Friday?
March 08, 2024
Amylyx Pharmaceuticals' AMX0035 trial results for ALS. Amylyx plans regulatory discussions and potential market actions. AMX0035's ongoing studies in PSP and Wolfram syndrome.
Via
Benzinga
Nasdaq Gains Over 50 Points; US Economy Adds 275,000 Jobs In February
March 08, 2024
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.04% to 38,805.52 while the NASDAQ rose 0.41%...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 08, 2024
Via
Benzinga
The Top 3 Biotech Stocks to Buy in March 2024
March 06, 2024
Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors.
Via
InvestorPlace
7 Oversold Russell 2000 Stocks to Add to Your February Buy List
February 25, 2024
Investors may want to jump into oversold Russell 2000 stocks. After a rough outing in 2023, many are starting to come back strong.
Via
InvestorPlace
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 22, 2024
Shares of Etsy, Inc.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 22, 2024
Via
Benzinga
NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday
February 22, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Amylyx Stock Rockets As ALS Drug Tacks On Another Triple-Digit Quarter
February 22, 2024
The company launched its first drug in late 2022. Sales grew rapidly, but look to slow down this year.
Via
Investor's Business Daily
Get Rich Quick With These 3 Biotech Stocks to Buy Now
February 13, 2024
The new cycle is coming your way to boost millionaire-making securities. Check out these three biotech stocks to buy.
Via
InvestorPlace
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
January 26, 2024
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.